July 12, 2009
Editor’s note: It is admitted in the following article that the vaccine is experimental and “will be introduced into the general population while regulators continue to carry out simultaneous clinical trials.” Under the Nuremberg Code, “voluntary consent of the human subject is absolutely essential” in the administration of experimental medical procedures. “This means that the person involved should have legal capacity to give consent; should be so situated as to be able to exercise free power of choice, without the intervention of any element of force, fraud, deceit, duress, over-reaching, or other ulterior form of constraint or coercion; and should have sufficient knowledge and comprehension of the elements of the subject matter involved as to enable him to make an understanding and enlightened decision.” If the government arrives at your door and demands you subject yourself to a toxic vaccine “assessed in five days,” politely tell them to take a flying leap.
[efoods]The path of a popular medicine from the laboratory to the chemist or doctor’s surgery can involve years of clinical trials on a select group of patients.
When the new vaccine for swine flu arrives in Britain, regulators said this weekend, it could be approved for use in just five days.
Regulators at the European Medicines Agency (EMEA) said the fast-tracked procedure has involved clinical trials of a “mock-up” vaccine similar to the one that will be used for the biggest mass vaccination programme in generations. It will be introduced into the general population while regulators continue to carry out simultaneous clinical trials.
The first patients in the queue for the jab – being supplied to the UK by GSK and Baxter Healthcare – may understandably be a little nervous at any possible side effects. A mass vaccination campaign against swine flu in America was halted in the 1970s after some people suffered Guillain-Barré syndrome, a disorder of the nervous system.